Krogerus advises Terveystalo on its acquisition of Silmäasema

Krogerus is advising Terveystalo on its acquisition of Silmäasema from Coronaria and the institutional and other shareholders of Silmäasema. The purchase price, cash- and debt-free, is approximately EUR 574 million, consisting of an initial cash payment of EUR 275 million and 36.5 million new shares in Terveystalo.

Silmäasema is the leading vision and eye health company in Finland in both private eye care and optical retail. Silmäasema serves approximately one million customers each year. The transaction strengthens Terveystalo's position in the growing eye care market by adding material scale and forming a broader platform for faster growth and stronger profitability.

Completion of the transaction is subject to approval by the Finnish Competition and Consumer Authority and other customary conditions.

The Krogerus team is led by Partners Marcus Möller, Antti Luhtala and Paul Raade. They are primarily assisted by Senior Associates Tuuli Merikallio Heiskanen, Kaarle Kivimäki, Markus Laine, Elina Mäkelä and Mikko Turunen and Associates Henna Olkkonen, Fiia Fonsén, Camilla Kakkola, Eemeli Kastikainen, Emma Kiviniemi, Aurora Kokkonen and Aleksi Kärnä. Partner Heidi Kivenjuuri advises on financing matters and she is assisted by Counsel Riina Toivonen-Vuong, Senior Associates Elina Terho and Essi Hällström and Associate Niki Maukonen. Partners Simo Autio and Martina Castrén advise on regulatory matters and they are assisted by Associates Riikka Kivitie and Regina Sedergren. Partner Pessi Honkasalo advises on technology, intellectual property and data protection matters and he is assisted by Senior Associate Iiris Rantanen and Associates Laura Oiva and Eveliina Piha.